Marc Quartulli
About Marc Quartulli
Marc Quartulli serves as the Vice President of Clinical Affairs at ConforMIS, Inc., a position he has held since 2011. He has extensive experience in clinical research and management, with previous roles at notable institutions including Dana-Farber Cancer Institute and Boston Scientific.
Work at ConforMIS
Marc Quartulli has served as Vice President of Clinical Affairs at ConforMIS, Inc. since 2011. In this role, he oversees clinical strategies and initiatives that support the company's mission in personalized orthopedic implants. His tenure at ConforMIS spans over 13 years, during which he has contributed to various clinical projects aimed at improving patient outcomes in joint replacement procedures. The company is based in Bedford, MA, where Quartulli plays a key role in aligning clinical operations with business objectives.
Previous Experience in Clinical Affairs
Before joining ConforMIS, Marc Quartulli held several positions in the clinical research field. He worked at Dana-Farber Cancer Institute as Program Manager for the Clinical Trial Network from 1996 to 2000. Following this, he was employed as a Senior Clinical Research Associate at Boston Scientific for nearly a year. Quartulli also served as Clinical Manager at NDO Surgical from 2001 to 2006 and as Director of Clinical Affairs at Facet Solutions Inc. from 2006 to 2010. His diverse experience in clinical roles has equipped him with a comprehensive understanding of clinical trial management and regulatory compliance.
Educational Background
Marc Quartulli earned a Bachelor of Science degree in Biology from Siena College, where he studied from 1990 to 1994. His educational background in biology laid the foundation for his career in clinical affairs and research. This academic experience has been instrumental in his ability to navigate complex clinical environments and contribute effectively to the development of medical technologies.
Early Career Development
Marc Quartulli began his career as a Technical Research Assistant at Brigham and Women's Hospital, where he worked from 1994 to 1996. This role provided him with essential experience in clinical research methodologies. His early career also included a position at Dana-Farber Cancer Institute, where he managed clinical trials, further enhancing his expertise in the clinical research landscape.